Name
Takeda Pharma OÜ
Registry code
10323690
VAT number
EE100006386
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.12.1997 (26)
Financial year
01.04-31.03
Capital
140 610.00 €
Activity
82991 - Other business support service activities n.e.c.
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Raul Salumets 15.07.1978 (46) | - | Procurator | - |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Acino Estonia OÜ 14072902 | - | - | - | Founder |
| 2019 28.09.2020 | 2020 19.10.2021 | 2021 07.10.2022 | 2022 22.09.2023 | |
|---|---|---|---|---|
| Total Revenue | 23 497 000 € | 18 274 000 € | 2 992 000 € | 1 870 000 € |
| Net profit (loss) for the period | 599 000 € | 1 256 000 € | -1 492 000 € | 85 000 € |
| Profit Margin | 3% | 7% | -50% | 5% |
| Current Assets | 24 863 000 € | 21 115 000 € | 3 932 000 € | 2 316 000 € |
| Fixed Assets | 81 000 € | 396 000 € | 327 000 € | 297 000 € |
| Total Assets | 24 944 000 € | 21 511 000 € | 4 259 000 € | 2 613 000 € |
| Current Liabilities | 5 674 000 € | 10 348 000 € | 2 236 000 € | 502 000 € |
| Non Current Liabilities | 32 000 € | 189 000 € | 143 000 € | 146 000 € |
| Total Liabilities | 5 706 000 € | 10 537 000 € | 2 379 000 € | 648 000 € |
| Share Capital | 141 000 € | 141 000 € | 141 000 € | 141 000 € |
| Equity | 19 238 000 € | 10 974 000 € | 1 880 000 € | 1 965 000 € |
| Employees | 9 | 11 | 11 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 477 256.39 € | 93 514.94 € | 93 292.83 € | 9 |
| 2023 Q4 | 109 761.26 € | 85 451.71 € | 84 233.04 € | 10 |
| 2023 Q3 | 901 118.68 € | 162 361.91 € | 162 085.93 € | 9 |
| 2023 Q2 | 755 563.78 € | 81 752.16 € | 77 631.22 € | 10 |
| 2023 Q1 | 512 176.67 € | 78 485.86 € | 77 542.7 € | 9 |
| 2022 Q4 | 558 329.36 € | 79 717.28 € | 77 112.38 € | 8 |
| 2022 Q3 | 263 733.75 € | 138 847.24 € | 141 032.72 € | 8 |
| 2022 Q2 | 843 808.93 € | 1 668 273.98 € | 71 509.93 € | 9 |
| 2022 Q1 | 1 195 797.43 € | 79 495.63 € | 78 849.35 € | 8 |
| 2021 Q4 | 848 507.12 € | 76 146.47 € | 75 207.55 € | 7 |
| 2021 Q3 | 1 023 935.93 € | 147 223.16 € | 155 101.21 € | 9 |
| 2021 Q2 | 13 251 587.47 € | 913 844.64 € | 75 749.97 € | 9 |
| 2021 Q1 | 4 944 801.33 € | 123 619.88 € | 65 020.29 € | 9 |
| 2020 Q4 | 5 130 072.87 € | 197 627.91 € | 66 209.45 € | 8 |
| 2020 Q3 | 4 886 962.65 € | 225 136.16 € | 99 207.28 € | 8 |
| 2020 Q2 | 11 218 935.57 € | 671 205.45 € | 55 308.16 € | 8 |
| 2020 Q1 | 9 431 292.62 € | 64 176.75 € | 44 782.28 € | 7 |
